Zura Bio Limited - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ZURA Nasdaq 2830 zurabio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Zura Bio Limited

Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer - Jan 21st, 2026 6:50 am
Zura Bio Reports Business Updates and Outlook for 2026 - Jan 12th, 2026 4:30 am
December 2025's Top Penny Stocks With Promising Potential - Dec 15th, 2025 11:05 am
Bullish Outlook on Zura Bio Limited (ZURA) Amid Tibulizumab Phase 2 Clinical Trial Progress - Nov 28th, 2025 11:26 pm
Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates - Nov 13th, 2025 4:30 am
Zura Bio And 2 Other Promising Penny Stocks For Your Watchlist - Oct 28th, 2025 6:05 am
Is Zura Bio’s (ZURA) Executive Severance Plan Hinting at Leadership Stability or Looming Funding Shifts? - Oct 4th, 2025 8:20 am
September 2025's Promising Penny Stocks Revealed - Sep 29th, 2025 12:05 pm
Spotlight On 3 Promising Penny Stocks With Over $60M Market Cap - Aug 20th, 2025 6:05 am
Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference - Aug 20th, 2025 4:30 am
Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates - Aug 14th, 2025 6:15 am
3 Penny Stocks With Market Caps Over $70M Worth Watching - Jul 18th, 2025 6:05 am
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jul 17th, 2025 2:30 pm
We're Not Very Worried About Zura Bio's (NASDAQ:ZURA) Cash Burn Rate - Jul 14th, 2025 5:18 am
Zura Bio Announces Chief Financial Officer Transition - Jul 1st, 2025 4:30 am
Zura Bio to Present at the Jefferies Global Healthcare Conference - May 27th, 2025 4:30 am
Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa - May 20th, 2025 4:30 am
Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates - May 8th, 2025 4:30 am
After losing 56% in the past year, Zura Bio Limited (NASDAQ:ZURA) institutional owners must be relieved by the recent gain - Apr 24th, 2025 4:34 am
Hopeful Week For Insiders Who Bought US$1.01m Of Zura Bio Stock - Mar 26th, 2025 9:16 am